Publication | Closed Access

Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer

Advanced Breast CancerBreast OncologyOncologyMedicineSerum Elimination Half-lifePathologyBreast CancerCancer TreatmentPharmacologyCancer ResearchEndocrine-related Cancer